30
Participants
Start Date
October 31, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
MEDI-560
MEDI-560 vaccine was a frozen preparation of live, attenuated rHPIV3cp45 virus filled into Becton Dickinson\^TM luer slip tip syringes. Each 0.2 mL dose contained 10\^5 TCID50 of MEDI-560 in a sucrose phosphate glutamate buffer.
Placebo
Placebo was a frozen preparation filled into Becton Dickinson\^TM luer slip-tip syringes. Each 0.2 mL dose contained sucrose phosphate buffer.
SUNY Upstate Medical University, Syracuse
Belleview Pediactric Assoc., Pittsburgh
St. Luke's Hospital, Bethlehem
University Physicians Internal Medicine, Huntington
Duke Health Center- Pickett Road, Durham
Homestead Clinical Research, Naranja
Miami Children's Hospital, Miami
University of South Florida College of Medicine Department of Pediatrics, Tampa
Holston Medical Group, Kingsport
Michael W. Simon, M.D., Lexington
University Hospitals Case Medical Center, Cleveland
Meridian Clinical Research LLC, Omaha
Tulane University, New Orleans
Arkansas Pediatric Clinic, Little Rock
Children's Investigational Research Program, Bentonville
Oklahoma State University Center for Health Sciences, Tulsa
Dixie Pediatrics, St. George
Children's Lung Specialists Ltd., Las Vegas
Madera Family Medical Group, Madera
Allergy Medical Group of the North Area, Roseville
Kapiolani Medical Center for Women and Children, Honolulu
Tufts-New England Medical Center, Boston
Cincinnati Children's Hospital Medical Center, Cincinnati
Lead Sponsor
MedImmune LLC
INDUSTRY